Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer

Published:2021-05 Issue: Volume:28 Page:24-31
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Haslett K.,Koh P.,Hudson A.,Ryder W.D.,Falk S.,Mullan D.,Taylor B.,Califano R.,Blackhall F.,Faivre-Finn C.

Funder

AstraZeneca

Manchester Biomedical Research Centre

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference35 articles.

1. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

2. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions;Bentzen;Nat Rev Clin Oncol,2007

3. Synergistic effects of crizotinib and radiotherapy in experimental EML4–ALK fusion positive lung cancer;Dai;Radiother Oncol,2015

4. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by Erlotinib (Tarceva);Chinnaiyan;Cancer Res,2005

5. Non–small cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation;Das;Cancer Res,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review;Frontiers in Oncology;2023-12-05

2. Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma;Cancer Biology & Therapy;2023-09-14

3. Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis;Molecular Biology Reports;2022-09-12

4. The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies;Frontiers in Oncology;2021-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3